Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy - Wikidata - awgldk - TriplyDB

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy

http://www.wikidata.org/entity/Q28285210

about

Testosterone deficiency in the aging male Testosterone Replacement Therapy and Prostate Cancer Incidence Pharmacologic and surgical therapies for sexual dysfunction in male cancer survivors Challenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapists Testosterone and prostate cancer: an evidence-based review of pathogenesis and oncologic risk Testosterone replacement therapy and the risk of prostate cancer Androgens and prostate disease Challenges in Testosterone Measurement, Data Interpretation, and Methodological Appraisal of Interventional Trials.Testosterone deficiency and replacement: Myths and realities.An update on male hypogonadism therapy.Current state of practice regarding testosterone supplementation therapy in men with prostate cancer The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis.Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men.Diagnosis and management of testosterone deficiency Testosterone therapy in men with prostate cancer: literature review, clinical experience, and recommendations.Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy Testosterone supplementation therapy in the treatment of patients with metabolic syndrome.A survey of Canadian urologists' opinions and prescribing patterns of testosterone replacement therapy in men on active surveillance for low-risk prostate cancer Risks of testosterone replacement therapy in men.Testosterone therapy and prostate cancer.Adult-onset hypogonadism: evaluation and role of testosterone replacement therapy.The evaluation and management of testosterone deficiency: the new frontier in urology and men's health.Serum testosterone level, testosterone replacement treatment, and prostate cancer.When and when not to use testosterone for palliation in cancer care.To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer.The safety of testosterone supplementation therapy in prostate cancer.Testosterone replacement therapy: who to evaluate, what to use, how to follow, and who is at risk?Elevated Dihydrotestosterone is Associated with Testosterone Induced Erythrocytosis.Update on Testosterone Replacement Therapy in Hypogonadal Men.Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results.Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen.Testosterone Therapy in Men With Prostate Cancer.Testosterone Therapy on Active Surveillance and Following Definitive Treatment for Prostate Cancer.Testosterone Therapy Among Prostate Cancer Survivors.Testosterone Therapy in Patients with Treated and Untreated Prostate Cancer: Impact on Oncologic Outcomes.Addressing the pressing issues related to testosterone administration to men with prostate cancer.Testosterone therapy and prostate cancer--safety concerns are well founded.Long-acting testosterone injections for treatment of testosterone deficiency after brachytherapy for prostate cancer.Effects of Testosterone on Benign and Malignant Conditions of the Prostate.

P2860

Q26770414-127F298E-F168-41B6-AC6A-CEF275BCED9A Q26771774-0479ACDA-F26D-4813-9E0C-B15C47C9450D Q26773724-4B4A7B1F-8970-4307-B71A-112A2E0EDD6B Q26773738-C9501F01-62EB-4346-A942-00279EC38CE4 Q26775766-FAFEA991-6FAE-4332-9B80-2D5F8741E6A8 Q26823279-C0D93DC2-5BF7-45AC-B068-667A27A11A5E Q27010093-094EC38E-6FEA-4750-8869-E766DBDF9017 Q31099075-8454A4BB-79CC-43AB-986E-F421F7F96DD8 Q34093530-A519A286-AC41-4BBB-BE5E-3FF82A0A4C30 Q34207540-EB07765A-0901-4E9E-8F3A-A02037A1EF3B Q34293663-06DF033C-3B89-422B-9C5B-9360B495A7D7 Q35549154-6CD3F8A2-64F2-4AEF-B765-733685A5C346 Q36287950-F14AE5C8-BB0D-41AF-AB00-A018D9613F3D Q36293061-1C611FA4-BCB7-41A4-837B-BEA97B360365 Q36293127-8CDAAAF2-4985-4F85-87EA-C77223DDD586 Q36530243-E07821FE-151C-4921-95EC-864449895396 Q37088526-FAE82704-DA1A-4E57-8A44-FCF4C5B2B4FD Q37301641-0BA31F45-BABE-4F5B-BAA7-00B0DA88648B Q37498164-48749B2B-B371-47FA-830F-5E1B15715556 Q37531045-BEBB96AB-ED77-4558-85C9-4050745E7E08 Q37531098-73CDFFE0-E673-414D-8017-70A1BE14F8E3 Q38133734-2137ADFE-E697-4AB5-993A-DE997B8E307D Q38155496-0AC84EA9-5FC1-4AFE-A813-815B1B367E66 Q38186655-5BE4FD7D-51D2-4C2C-B706-D00D4098ED49 Q38212063-0BA7ABE0-A669-4AF9-B062-2880498E6210 Q38234728-986184FF-965B-4C65-B146-372457AA730A Q38285100-E779C029-0471-4B71-90A7-6B32C1DA0DCA Q38321722-D9502FAC-A8B7-4DFA-9D96-84707D946500 Q38528376-5E7879C4-4E40-4E0B-929A-3D33627EEF69 Q38532217-EF6C17D2-C028-431D-B464-E794D96FE0B3 Q38573757-12E09527-E51E-47A4-84D0-D1F13FA18E10 Q38607545-A02FD752-45E8-4BB8-B823-9016E27372D9 Q38683604-846390A6-9B52-4663-943C-398E8C125711 Q38739186-F97E76AA-A393-4F72-A170-6D915AAC70F5 Q38913362-AECE239E-A67D-43D5-818B-7FEB21EB548F Q41105030-495EF524-78B0-4AAE-B7AF-5E4BD576BDCF Q41259705-59DC4596-0F74-423A-B394-FCBC3A4FE3BA Q43594011-0D98C9F3-F885-49F8-9622-3F45A3130A29 Q45351575-F1BEFAE5-85F5-429E-B09D-157C8BBC76BE Q47746789-82ACC167-2A2B-492E-9A65-A4A7D8C92221

P2860

Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy

http://www.wikidata.org/entity/Q28285210

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Testosterone replacement thera ...... er after radical prostatectomy

@ast

Testosterone replacement thera ...... er after radical prostatectomy

@en

Testosterone replacement thera ...... er after radical prostatectomy

@nl

type

label

Testosterone replacement thera ...... er after radical prostatectomy

@ast

Testosterone replacement thera ...... er after radical prostatectomy

@en

Testosterone replacement thera ...... er after radical prostatectomy

@nl

prefLabel

Testosterone replacement thera ...... er after radical prostatectomy

@ast

Testosterone replacement thera ...... er after radical prostatectomy

@en

Testosterone replacement thera ...... er after radical prostatectomy

@nl

P1433

Q28285210-818FBD43-1E53-4884-961A-876D1184C399

P1476

Q28285210-A349332C-85F5-4C4F-B14A-2EA2659600B8

P2093

Q28285210-49CA5280-DE40-4D13-8D05-A55852085D4E

Q28285210-69E65490-A3F5-4AE9-82C6-D556AFC76011

Q28285210-9A96A9C5-F4E4-42EF-B2E1-69906E0568F4

Q28285210-A1D0C6A6-7185-4DFE-BFD6-2E86C8F22F7E

Q28285210-A6A5DD0F-090F-4DAC-B596-3EB96F33CC17

Q28285210-CCF734A1-49B4-4AC8-9155-3FADE85A27E9

Q28285210-CF3CBED2-530A-40E7-893D-D6F6B72634EE

Q28285210-F9ADDAD6-99F5-4932-AECF-5C91B0391474

P2860

Q28285210-09332B80-B1D2-426D-8F82-802F98769EF4

Q28285210-13B197A4-EC78-4329-8D52-E5BEB9E6F46E

Q28285210-1F7FF91D-F9F7-4902-93FD-9A286FE07B1A

Q28285210-23ED24C8-D814-45F7-B7DA-756D2BA138BE

Q28285210-2C02433E-7E8E-49D6-AD2C-C96DC7464596

Q28285210-3196B470-34B0-48A7-8E04-82F2DE997AFC

Q28285210-40E9B746-6F4A-42B0-9672-96EF1685596B

Q28285210-653F70A7-B22F-470B-B8C8-A7204A7C2D72

Q28285210-709F7020-245F-43FE-B10F-6012A05C2ABB

Q28285210-7E932B15-5283-4F1A-8147-708048AB359D

P304

Q28285210-AD569B4D-EAB6-4C62-B6F8-7A73860EB75E

P31

Q28285210-C79D7886-09DC-4AA8-A468-1D7D741203B3

P356

Q28285210-44570738-BF5D-4CC9-B32E-D2AF8579857F

P407

Q28285210-2764BF40-D213-4619-A161-EF2D69A64B6C

P433

Q28285210-EFBFA105-11B8-44C1-A27C-BB0853320B8E

P478

Q28285210-F0E4404C-76E0-4423-9A0F-78AEBEECD54D

P50

Q28285210-114A31F4-B75F-4749-8A90-ADF42C72269D

P577

Q28285210-99D508F8-BCF8-453F-BB77-FF92DD115235

P698

Q28285210-3632A8CF-05B3-49D8-BC23-5FD9C28DA441

P932

Q28285210-D77C6909-0F7C-4858-9CA5-5BFE63760BC3

P356

J.JURO.2013.02.002

P1433

The Journal of Urology

P1476

Testosterone replacement thera ...... er after radical prostatectomy

@en

P2093

Alexander W Pastuszak

http://www.w3.org/2001/XMLSchema#string

Brian J Miles

http://www.w3.org/2001/XMLSchema#string

Guilherme Godoy

http://www.w3.org/2001/XMLSchema#string

Joceline S Liu

http://www.w3.org/2001/XMLSchema#string

Kumaran Sathyamoorthy

http://www.w3.org/2001/XMLSchema#string

Larry I Lipshultz

http://www.w3.org/2001/XMLSchema#string

Mohit Khera

http://www.w3.org/2001/XMLSchema#string

Win Shun Lai

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits and risks of testosterone replacement therapy: a review

Prostate specific antigen progression after radical prostatectomy in African-American men versus white men.

Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia.

Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth.

Risks of testosterone-replacement therapy and recommendations for monitoring.

Androgen replacement after curative radical prostatectomy for prostate cancer in hypogonadal men.

Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.

Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

P304

639-644

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JURO.2013.02.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

190

http://www.w3.org/2001/XMLSchema#string

P50

Amy Marcia Pearlman

P577

2013-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23395803

http://www.w3.org/2001/XMLSchema#string

P932

4544840

http://www.w3.org/2001/XMLSchema#string